Details of the Drug Inactive Ingredient (DIG)
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
Minocycline
|
API Info |
Streptococcus bacterial infection [ICD-11: 1C41]
|
[1] | |||
Acyclovir
|
API Info |
Herpes zoster [ICD-11: 1E91]
|
[2] | |||
Didanosine
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[3] | |||
Oseltamivir
|
API Info |
Influenza virus infection [ICD-11: 1E30]
|
[4] | |||
Stavudine
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[5] | |||
Vancomycin
|
API Info |
Methicillin-resistant staphylococcus infection [ICD-11: 1D01]
|
[6] | |||
Cefaclor
|
API Info |
Clostridium difficile infection [ICD-11: 1A04]
|
[7] | |||
Itraconazole
|
API Info |
Blastomycosis [ICD-11: 1F22]
|
[8] | |||
Ampicillin
|
API Info |
Endocarditis [ICD-11: 1B12]
|
[9] | |||
Paromomycin
|
API Info |
Amebiasis [ICD-11: 1A36]
|
[10] | |||
ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
Temozolomide
|
API Info |
Brain cancer [ICD-11: 2A00]
|
[11] | |||
Hydroxyurea
|
API Info |
Chronic myelogenous leukaemia [ICD-11: 2A20]
|
[12] | |||
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Fenofibrate
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[13] | |||
Phentermine
|
API Info |
Obesity [ICD-11: 5B81]
|
[14] | |||
Calcium acetate
|
API Info |
Hyperphosphatemia [ICD-11: 5C64]
|
[15] | |||
Bromocriptine
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[16] | |||
Zinc acetate
|
API Info |
Hyperphosphatemia [ICD-11: 5C64]
|
[17] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Fluoxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[18] | |||
Venlafaxine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[19] | |||
Hydroxyzine
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[20] | |||
Methylphenidate
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[21] | |||
Dexmethylphenidate
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[22] | |||
Ziprasidone
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[23] | |||
Atomoxetine
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[24] | |||
Lithium carbonate
|
API Info |
Bipolar disorder [ICD-11: 6A60]
|
[25] | |||
Imipramine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[26] | |||
Fluvoxamine
|
API Info |
Obsessive-compulsive disorder [ICD-11: 6B20]
|
[27] | |||
Loxapine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[28] | |||
Lisdexamfetamine
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[29] | |||
Clomipramine
|
API Info |
Obsessive-compulsive disorder [ICD-11: 6B20]
|
[30] | |||
Tiotixene
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[31] | |||
Trimipramine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[32] | |||
Oxazepam
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[33] | |||
Naltrexone
|
API Info |
Alcohol dependence [ICD-11: 6C40]
|
[34] | |||
ICD Disease Classification 07 | Sleep-wake disorder | Click to Show/Hide | ||||
Temazepam
|
API Info |
Insomnia [ICD-11: 7A00]
|
[35] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Morphine
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[36] | |||
Valproic acid
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[37] | |||
Propranolol
|
API Info |
Migraine [ICD-11: 8A80]
|
[38] | |||
Carbamazepine
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[39] | |||
Phenytoin
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[40] | |||
Zonisamide
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[41] | |||
Rivastigmine
|
API Info |
Alzheimer disease [ICD-11: 8A20]
|
[42] | |||
Ketoprofen
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[43] | |||
ICD Disease Classification 09 | Visual system disease | Click to Show/Hide | ||||
Acetazolamide
|
API Info |
Glaucoma [ICD-11: 9C61]
|
[44] | |||
ICD Disease Classification 10 | Ear/mastoid process disease | Click to Show/Hide | ||||
Diphenhydramine
|
API Info |
Meniere disease [ICD-11: AB31]
|
[45] | |||
Amoxicillin
|
API Info |
Acute otitis media [ICD-11: AB00]
|
[46] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Diltiazem
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[47] | |||
Ramipril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[48] | |||
Verapamil
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[49] | |||
Propafenone
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[50] | |||
Nitroglycerin
|
API Info |
Acute coronary syndrome [ICD-11: BA4Z]
|
[51] | |||
Acebutolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[52] | |||
Disopyramide
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[53] | |||
Mexiletine
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[54] | |||
ICD Disease Classification 12 | Respiratory system disease | Click to Show/Hide | ||||
Benzonatate
|
API Info |
Asthma [ICD-11: CA23]
|
[55] | |||
Fexofenadine
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[56] | |||
Cefdinir
|
API Info |
Pneumocystis pneumonia [ICD-11: CA40]
|
[57] | |||
Cefadroxil
|
API Info |
Acute tonsillitis [ICD-11: CA03]
|
[58] | |||
Budesonide
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[59] | |||
Theophylline
|
API Info |
Chronic obstructive pulmonary disease [ICD-11: CA22]
|
[60] | |||
ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
Doxycycline
|
API Info |
Periodontal disease [ICD-11: DA0C]
|
[61] | |||
Omeprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[62] | |||
Lansoprazole
|
API Info |
Duodenal ulcer [ICD-11: DA63]
|
[63] | |||
Esomeprazole
|
API Info |
Duodenal ulcer [ICD-11: DA63]
|
[64] | |||
Dicyclomine
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[65] | |||
Mycophenolate mofetil
|
API Info |
Crohn disease [ICD-11: DD70]
|
[66] | |||
Tacrolimus
|
API Info |
Ulcerative colitis [ICD-11: DD71]
|
[67] | |||
Ursodeoxycholic acid
|
API Info |
Hepatic fibrosis/cirrhosis [ICD-11: DB93]
|
[68] | |||
Nizatidine
|
API Info |
Peptic ulcer [ICD-11: DA61]
|
[69] | |||
Trimethobenzamide
|
API Info |
Functional nausea/vomiting [ICD-11: DD90]
|
[70] | |||
Balsalazide
|
API Info |
Ulcerative colitis [ICD-11: DD71]
|
[71] | |||
ICD Disease Classification 14 | Skin disease | Click to Show/Hide | ||||
Hydrochlorothiazide
|
API Info |
Luid retention [ICD-11: EF02]
|
[72] | |||
Clindamycin
|
API Info |
Acne vulgaris [ICD-11: ED80]
|
[73] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Indomethacin
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[74] | |||
Celecoxib
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[75] | |||
Etodolac
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[76] | |||
Phenylephrine
|
API Info |
Juvenile rheumatoid arthritis [ICD-11: FA24]
|
[77] | |||
Piroxicam
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[78] | |||
Rifampicin
|
API Info |
Osteoporosis [ICD-11: FB83]
|
[79] | |||
ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
Terazosin
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[80] | |||
Tamsulosin
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[81] | |||
Prazosin
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[82] | |||
Danazol
|
API Info |
Endometriosis [ICD-11: GA10]
|
[83] | |||
Trospium
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[84] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
G-protein coupled receptor (GPCR) | ||||||
DBT Name: Adenosine receptor A3 (AA3R) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 0.48 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | AA3R_HUMAN | |||||
DBT Name: Muscarinic receptor M1 (ACM1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | EC50 > 1 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ACM1_HUMAN | |||||
DBT Name: Muscarinic receptor M2 (ACM2) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 0.68 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ACM2_HUMAN | |||||
DBT Name: Opioid receptor mu (OPRM1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 0.8 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | OPRM_HUMAN | |||||
DBT Name: Serotonin receptor 1A (5HT1A) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 2.4 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | 5HT1A_HUMAN | |||||
DBT Name: Alpha-1A adrenoceptor (ADA1A) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | EC50 > 3 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ADA1A_HUMAN | |||||
Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 0.48 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ADA1A_HUMAN | |||||
DBT Name: Alpha-2A adrenoceptor (ADA2A) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 14 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ADA2A_HUMAN | |||||
DBT Name: Dopamine D1 receptor (DRD1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 2.1 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | DRD1_HUMAN | |||||
DBT Name: Dopamine D3 receptor (DRD3) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 1.5 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | DRD3_HUMAN | |||||
DBT Name: Histamine H3 receptor (HRH3) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 21 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | HRH3_HUMAN | |||||
DBT Name: Thromboxane A2 receptor (TBXA2R) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | EC50 > 1 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | TA2R_HUMAN | |||||
Oxidoreductase (ORase) | ||||||
DBT Name: Prostaglandin G/H synthase 1 (COX-1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 2.6 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PGH1_HUMAN | |||||
DBT Name: Prostaglandin G/H synthase 2 (COX-2) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 3 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PGH2_HUMAN | |||||
Transferase (TFase) | ||||||
DBT Name: Arginine methyltransferase 1 (PRMT1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Ki = 0.7 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ANM1_HUMAN | |||||
DBT Name: VEGF-2 receptor (KDR) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 12 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | VGFR2_HUMAN | |||||
Hydrolase (HDase) | ||||||
DBT Name: Acetylcholinesterase (ACHE) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 2 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ACES_HUMAN | |||||
DBT Name: Phosphodiesterase 3A (PDE3A) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 0.1 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PDE3A_HUMAN | |||||
DBT Name: Phosphodiesterase 4D (PDE4D) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 0.9 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PDE4D_HUMAN | |||||
DBT Name: Coagulation factor IIa (F2) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 25 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | THRB_HUMAN | |||||
Primary active transporter (PAT) | ||||||
DBT Name: Bile salt export pump (BSEP) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 < 10000 nM (estimated based on the structural similarity with CHEMBL2359093 ) | [86] | ||||
Structural Similarity | Tanimoto coefficient = 0.857954545 | |||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ABCBB_HUMAN | |||||
Potential-driven transporter (PDT) | ||||||
DBT Name: Organic anion transporter 1 (OAT1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Ki = 0.064 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | S22A6_HUMAN | |||||
DBT Name: Acetylcholine VAChT transporter (SLC18A3) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 9700 nM (estimated based on the structural similarity with CHEMBL2359093 ) | [87] | ||||
Structural Similarity | Tanimoto coefficient = 0.857954545 | |||||
Tested Species | Rattus norvegicus (Rat) | |||||
UniProt ID | VACHT_RAT | |||||
DBT Name: Solute carrier SLCO2B1 (OATPB) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Inhibition ratio = 77 % (tested by experiment) | [88] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | SO2B1_HUMAN | |||||
Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Ki = 1 uM (tested by experiment) | [88] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | SO2B1_HUMAN | |||||
Experiment (3) for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Ki = 0.6 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | SO2B1_HUMAN | |||||
Transmembrane channel/porin (TC/P) | ||||||
DBT Name: Potassium channel Kv11.1 (KCNH2) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 17 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | KCNH2_HUMAN | |||||
Nuclear receptor (NR) | ||||||
DBT Name: Androgen receptor (AR) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 28 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ANDR_HUMAN | |||||
DBT Name: Estrogen receptor alpha (ESR1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 18 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ESR1_HUMAN | |||||
DBT Name: Progesterone receptor (PGR) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 30 uM (tested by experiment) | [85] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PRGR_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.